
親愛的合作夥伴:
為推動台灣頂尖健康醫療、生技、醫美與保健食品產業拓展國際市場,Aivita Health Group 與 Axel Biotechnology Inc. 謹訂於 2025 年 10 月 4日至 5 日,假杜拜 DIFC Capital Club 隆重舉辦「2025 杜拜台灣醫療與健康博覽會(Taiwan Medical & Wellness Expo 2025 – Dubai Edition)」。
本次展會為「台灣健康創新系列活動」之全球旗艦場次,將聚焦於再生醫學、智慧健康科技、醫美創新及營養保健,邀集杜拜及中東地區醫療機構、產業領袖、專業買主、投資人與媒體代表共襄盛舉,打造國際交流與產業媒合的重要平台,進一步提升台灣品牌於全球高端醫療與健康市場之影響力。
Dear Valued Partner,
To promote the global presence of Taiwan’s leading health, biomedical, aesthetics, and nutraceutical industries, Aivita Health Group and Axel Biotechnology Inc. are honored to host the "Taiwan Medical & Wellness Expo 2025 – Dubai Edition" at DIFC Capital Club, Dubai, from October 4 to 5, 2025.
As the flagship event of the Taiwan Health Innovation Showcase Series, this expo will spotlight cutting-edge developments in regenerative medicine, smart health technology, aesthetic innovation, and nutritional science. It will bring together medical institutions, industry leaders, professional buyers, investors, and media representatives from Dubai and the broader Middle East. The showcase aims to create a dynamic platform for international exchange and strategic collaboration, strengthening the visibility and impact of Taiwanese brands in the global premium healthcare market.
活動資訊|Event Details
日期|Date: 2025 年 10 月 4 日(六)~ 10 月 5 日(日) | October 4–5, 2025
地點|Venue: 杜拜 DIFC Capital Club | Capital Club Dubai, DIFC Gate Village, Building 3
參與對象|Audience: 醫療、醫美、保健產業專業人士、買主與投資人 | Professionals, buyers, and investors in healthcare, aesthetics, and wellness sectors
展出主題|Focus Areas: 再生醫學、生技醫療、保健食品、醫美科技等 | Regenerative medicine, biomedical tech, health supplements, and aesthetic innovations
活動形式|Format: 靜態展示、簡報發表、商務媒合、雞尾酒交流 | Product displays, presentations, B2B matchmaking, and networking cocktails
敬請於 2025 年 8 月 20 日前回覆參展或媒合意願,主辦單位將提供展位配置與配套安排。
Please confirm your intent to participate or request matchmaking arrangements by July 20, 2025. The organizing team will provide booth allocation and event logistics accordingly.
聯絡資訊|Contact Information
Email: [email protected]
Tel: +886-4-22020968
Mobile: +886-923-874-683
